Rendu-Osler-Weber syndrome or hereditary hemorrhagic telangiectasia is an autosomal dominant vascular disease involving multiple systems whose main pathological change is the presence of abnormal arteriovenous communications. Most common symptoms include skin and mucosal telangiectasias, epistaxis, gastrointestinal, pulmonary and intracerebral bleeding. The key imaging finding is the presence of visceral arteriovenous malformations. The diagnosis is based on clinical criteria and can be confirmed by molecular biology techniques. Treatment includes measures for management of epistaxis, as well as surgical excision, radiotherapy and embolization of arteriovenous malformations, with emphasis on endovascular treatment. The present pictorial essay includes a report of three typical cases of this entity and a literature review. Keywords: Rendu-Osler-Weber; Hereditary hemorrhagic telangiectasia; Arteriovenous fistula; Epistaxis.
and petechial lesions with perioral and periungueal distribution. At clinical examination, an ulcerated lesion was identified in the nasal septum. Such lesion was submitted to biopsy whose histopathological result revealed a chronic inflammatory process, with presence of round-shaped structures suggestive of the amastigote form of Leishmania sp. Chest radiography was performed as part of the investigation for the infectious condition (leishmaniasis), and detected the presence of a pulmonary nodule ( Figure 1A ). For further investigation, chest computed tomography (CT) was requested ( Figure 1B ) and demonstrated the vascular nature of the lesion. The hypothesis of HHT was raised and supplementary studies were requested -abdominal and cranial CT and magnetic resonance imaging (MRI) - (Figures 1 to 4) . Epistaxis was treated with local tamponade. The followup was discontinued by the patient. bed (3) . Most common clinical manifestations include skin and mucosal telangiectasias and epistaxis, besides gastrointestinal, pulmonary and intracerebral bleeding (4) (5) (6) . The reported prevalence of this disease is of 1-2/100,000 live neonates (7) , but it may reach 1/3,500 to 1/5,000 in some regions . In the present study, the authors report three cases of this syndrome, highlighting the diagnostic criteria and imaging findings, with a literature review.
CASE 1
A female, 57-year-old, brown-skinned patient complaining of repetition epistaxis
INTRODUCTION
Rendu-Osler-Weber syndrome or hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease with variable penetrance , involving multiple organs and systems, and characterized by the presence of angiodysplastic lesions which cause communication between arteries and veins without interposition of a capillary http://dx.doi.org/10.1590/S0100-39842013000300011 
CASE 2
A female, 43-year-old, white patient complaining of recurrent epistaxis for about 20 years, besides reddish lesions in her lips, tongue, hands and trunk. The patient underwent chest CT and abdominal CT angiography, which revealed typical findings of HHT ( Figures 5 and 6 ). In no occasion treatment with tamponade was required and the patient is under follow-up for three years and has not presented any complication. This patient has also a daughter with recurrent epistaxis since the age of four, whose investigation is currently being initiated in the authors' institution, with no imaging study available until the present moment.
CASE 3
A female, 36-year-old, white inpatient with fever was submitted to chest radiography which demonstrated the presence of pulmonary nodules. At physical examination, the patient presented digital hypocratism. Chest CT demonstrated the vascular nature of the lesions visualized at radiography ( Figure 7 ). The infectious focus related to the fever was diagnosed as pyelonephritis not related to the alterations of HHT, satisfactorily treated with antibiotic therapy. During the diagnostic investigation, the positive family history for the disease could be revealed, since the patient had a relative with a past history of recurrent epistaxis. No specific treatment was required and the patient is under follow-up for six months, with neither complications nor symptoms related to the findings of the disease.
DISCUSSION
The imaging evaluation of the vascular system has been discussed in a range of recent publication in the Brazilian radiological literature (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . HHT is diagnosed on the basis of the presence of three among four Curacao criteria , as follows 1) skin and mucosal telangiectasias; 2) recurrent spontaneous epistaxis; 3) visceral arteriovenous malformations (AVMs); 4) positive family history. HHT can be confirmed by means of the identification of the involved mutations with molecular biology techniques. All the cases reported in the present essay were diagnosed as HHT according the Curacao criteria.
Two mutations are involved in the pathogenesis of this disease, namely: a) mutation of the endoglin gene located in the chromosome 9q that determines type 1 HHT, with marked pulmonary involvement; b) mutation of the activin gene located in the chromosome 12q that determines type 2 HHT with predominantly extrapulmonary involvement (4) . The cases herein described were not genetically analyzed.
HHT is characterized by progressive lifetime symptoms. Epistaxis is the first manifestation, with onset around the age of ten, and with increasingly severe episodes. Two of the cases presently reported had epistaxis as primary symptom, while the other had incidental detection of pulmonary lesions. The onset of telangiectasias is also progressive and the most common sites are the lips, tongue, palate, fingers and face. The main complications of the disease originate from pulmonary AVMs resulting in right-to-left shunting which may cause dyspnea, hemoptysis, paradoxical embolism and cerebral abscesses, which have not occurred in any of the cases presently reported. Hepatic vascular (arterioportal, arteriovenous and portosystemic) malformations may also cause right-to-left shunting and determine varied degrees of pulmonary hypertension, heart failure and hepatic encephalopathy. In a study with 35 children, Giordano et al.
(21) have found nasal telangiectasias in 68%, skin and mucosal telangiectasias (fingers, lips, oral cavity) in 79%, pulmonary AVMs in 53%, hepatic AVMs in 47% and brain MAVs and/or ischemic brain alterations secondary to pulmonary AVMs in 12% of the patients. Brain AVMs may cause migraine and intraparenchymal and/or subarachnoid hemorrhage. None of the cases described in the present study presented neurological symptoms.
Another neuroimaging finding that may aid in the diagnosis of HHT -already described in association with congenital portosystemic shunts and clearly seen in the case 1 -, is the presence of hypersignal on T1-weighted images of the basal nuclei, particularly of the globus pallidus, which indicates accumulation of manganese in the central nervous system. Such finding is nonspecific and may be associated with conditions such as parenteral nutrition, chronic hepatopathy with or without encephalopathy, acquired or congenital portosystemic shunts, and chronic dialytic renal failure with increased manganese serum levels (22, 23) . Differential diagnoses include capillary skin malformations with visceral AVMs (involving soft parts, brain or bones) caused by RASA1 mutation; Adams-Oliver syndrome (with skin telangiectasias, pulmonary AVMs, and limb and scalp defects); or vascular retino-encephalic malformation (Wyburn-Mason syndrome), which may falsely meet the Curacao criteria for HHT.
The treatment for HHT includes measures for management of epistaxis (local tamponade and laser); management of iron deficiency anemia with iron supplementation and transfusions, as necessary; management of pulmonary, cerebral and hepatic AVMs with careful embolization or, alternatively, surgical resection, radiotherapy and liver transplantation, respectively (1) . The two cases with epistaxis were treated with local tamponade, while one of the patients was submitted to endovascular embolization of pulmonary AVM because of hemoptysis.
The most frequent situations related to this rare syndrome in the radiologist's daily routine include: a) incidental finding of a visceral AVM in a patient without previous diagnosis of HHT; b) examination targeted to the investigation or management of visceral alterations in patients already diagnosed with HHT. In the present cases, it is observed that the diagnosis was achieved mainly by the detection of epistaxis and hemoptysis, while in one case a vascular pulmonary lesion was incidentally found. Therefore, the authors conclude that, in the presence of a finding suggestive of visceral AVM, it is important that the radiologist has the HHT diagnostic criteria in mind, either asking the requesting physician or directly asking the patient at the moment of the procedure. In the cases where patients with recurrent epistaxis or hemoptysis submitted to chest or abdominal imaging, attention should be paid to the presence of lesions originating from vascular malformations. Once the diagnosis of HHT is established in adult patients, screening for vascular abdominal (particularly hepatic) and pulmonary lesions should be performed in the children of such patients' families, with abdominal ultrasonography, plain radiography and, eventually, chest CT (9) .
